Clinical Trial Update: Squalamine for the Treatment in Proliferative Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Squalamine for proliferative diabetic retinopathy has completed; no trial results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Squalamine (squalamine)

Snippet

Sponsor: Elman Retina Group | Conditions: Retinal Neovascularization | Phase 2 | Status: COMPLETED